Hot Features
プレミアム
PTC Therapeutics Inc (PTCT)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -2.81k | 130.72k | Derivative Exercise and Sale | 25.69 - 72.67 | 105.21k | - |
| 2026-05-14 | Dr. Matthew B. KleinCEO & Director | -12.57k | 917.15k | 売り | 72.46 - 73.08 | 116.19k | -9.76% |
| 2026-05-08 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -3.54k | 114.82k | Derivative Exercise and Sale | 46.54 - 79.31 | 105.21k | - |
| 2026-04-06 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -2.27k | 68.01k | Derivative Exercise and Sale | 39.42 - 69.75 | 105.21k | - |
| 2026-04-02 | Dr. Lee Scott GoldenExec. VP & Chief Medical Officer | -829.00 | 56.36k | 売り | 67.99 | 28.51k | -2.83% |
| 2026-04-01 | Dr. Neil AlmsteadChief Technical Operations Officer | -52.00k | 3.59M | Automatic Disposition | 68.89 - 70.30 | 15.71k | -76.80% |
| 2026-03-12 | Dr. Matthew B. KleinCEO & Director | -2.66k | 170.58k | 売り | 64.08 | 125.11k | -2.08% |
| 2026-03-10 | Ms. Stephanie Smith OkeyIndependent Director | -15.17k | 551.62k | Derivative Exercise and Sale | 33.63 - 70.00 | 5.67k | - |
| 2026-03-05 | Dr. Neil AlmsteadChief Technical Operations Officer | -3.99k | 252.82k | Automatic Disposition | 63.38 | 67.71k | -5.56% |
| 2026-03-05 | Dr. Lee Scott GoldenExec. VP & Chief Medical Officer | -10.00k | 633.80k | Automatic Disposition | 63.38 | 28.03k | -26.29% |
| 2026-03-05 | Ms. Stephanie Smith OkeyIndependent Director | -6.33k | 401.39k | Automatic Disposition | 63.38 | 5.67k | -52.78% |
| 2026-02-19 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -3.02k | 209.76k | Automatic Disposition | 68.54 - 69.82 | 105.21k | -2.79% |
| 2026-02-18 | Dr. Neil AlmsteadChief Technical Operations Officer | -3.12k | 216.47k | 売り | 69.36 | 71.70k | -4.17% |
| 2026-02-18 | Mr. Eric PauwelsChief Business Officer | -3.02k | 209.40k | 売り | 69.36 | 25.12k | -10.73% |
| 2026-02-18 | Mr. Pierre GravierCFO | -2.99k | 207.53k | 売り | 69.36 | 27.94k | -9.67% |
| 2026-02-18 | Dr. Lee Scott GoldenExec. VP & Chief Medical Officer | -2.48k | 172.29k | 売り | 69.36 | 52.38k | -4.53% |
| 2026-02-18 | Ms. Christine UtterSenior VP, CAO & Head of People Services | -2.49k | 172.98k | 売り | 69.36 | 39.45k | -5.95% |
| 2026-02-18 | Dr. Matthew B. KleinCEO & Director | -7.37k | 511.25k | 売り | 69.36 | 121.77k | -5.71% |
| 2026-02-17 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -2.81k | 122.65k | Derivative Exercise and Sale | 25.69 - 70.13 | 64.48k | - |
| 2026-02-18 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -3.08k | 213.70k | 売り | 69.36 | 64.48k | -4.56% |
| 2026-01-08 | Dr. Neil AlmsteadChief Technical Operations Officer | -940.00 | 71.86k | 売り | 76.45 | 72.41k | -1.28% |
| 2026-01-08 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -1.29k | 98.31k | 売り | 76.45 | 66.61k | -1.89% |
| 2026-01-08 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -5.06k | 390.77k | Automatic Disposition | 76.56 - 79.52 | 66.61k | -7.06% |
| 2026-01-08 | Mr. Eric PauwelsChief Business Officer | -1.45k | 111.16k | 売り | 76.45 | 27.29k | -5.06% |
| 2026-01-08 | Mr. Eric PauwelsChief Business Officer | -5.89k | 454.79k | Automatic Disposition | 76.42 - 78.70 | 27.29k | -17.76% |
| 2026-01-08 | Dr. Lee Scott GoldenExec. VP & Chief Medical Officer | -866.00 | 66.21k | 売り | 76.45 | 39.65k | -2.14% |
| 2026-01-08 | Dr. Matthew B. KleinCEO & Director | -2.51k | 192.20k | 売り | 76.45 | 106.39k | -2.31% |
| 2026-01-08 | Ms. Christine UtterSenior VP, CAO & Head of People Services | -1.03k | 79.05k | 売り | 76.45 | 37.59k | -2.68% |
| 2026-01-06 | Ms. Christine UtterSenior VP, CAO & Head of People Services | -2.62k | 201.92k | 売り | 76.95 - 77.45 | 38.63k | -6.34% |
| 2026-01-06 | Dr. Neil AlmsteadChief Technical Operations Officer | -2.41k | 186.10k | 売り | 76.95 - 77.48 | 73.35k | -3.18% |
| 2026-01-06 | Mr. Eric PauwelsChief Business Officer | -3.14k | 242.42k | 売り | 76.95 - 77.48 | 34.64k | -8.31% |
| 2026-01-06 | Dr. Lee Scott GoldenExec. VP & Chief Medical Officer | -1.98k | 152.86k | 売り | 76.95 - 77.48 | 40.51k | -4.66% |
| 2026-01-06 | Dr. Matthew B. KleinCEO & Director | -8.17k | 629.90k | 売り | 76.95 - 77.48 | 108.90k | -6.97% |
| 2026-01-06 | Mr. Pierre GravierCFO | -2.14k | 164.60k | 売り | 76.95 | 24.64k | -7.99% |
| 2026-01-07 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -3.38k | 132.75k | Derivative Exercise and Sale | 38.10 - 78.98 | 72.96k | - |
| 2026-01-06 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -3.24k | 250.27k | 売り | 76.95 - 77.48 | 72.96k | -4.25% |
| 2026-01-05 | Ms. Emma ReeveIndependent Director | -734.00 | 21.62k | Derivative Exercise and Sale | 46.54 - 76.00 | 6.67k | - |
| 2026-01-02 | Dr. Glenn Daniel SteeleIndependent Director | -12.00k | 545.88k | Derivative Exercise and Sale | 30.86 - 76.35 | 16.17k | - |
| 2026-01-05 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -2.27k | 81.87k | Derivative Exercise and Sale | 39.42 - 76.79 | 67.45k | - |
| 2025-12-30 | Dr. Matthew B. KleinCEO & Director | -8.09k | 619.94k | 売り | 76.64 | 92.81k | -8.02% |
| 2025-12-19 | Mr. Eric PauwelsChief Business Officer | -20.51k | 248.16k | Derivative Exercise and Sale | 18.01 - 78.43 | 17.52k | - |
| 2025-12-17 | Mr. Eric PauwelsChief Business Officer | -43.49k | 578.26k | Derivative Exercise and Sale | 18.01 - 76.00 | 17.52k | - |
| 2025-12-16 | Mr. Michael SchmertzlerIndependent Chairman of the Board | 24.00k | 740.64k | Derivative Exercise and Retained Stock | 30.86 | 1.54M | 1.59% |
| 2025-12-03 | Ms. Emma ReeveIndependent Director | -733.00 | 23.51k | Derivative Exercise and Sale | 46.54 - 78.62 | 4.33k | - |
| 2025-12-02 | Dr. Matthew B. KleinCEO & Director | -3.43k | 271.05k | 売り | 79.07 | 82.15k | -4.01% |
| 2025-11-24 | Dr. Neil AlmsteadChief Technical Operations Officer | -107.50k | 5.57M | Derivative Exercise and Sale | 18.01 - 85.37 | 56.54k | - |
| 2025-11-24 | Dr. Allan Steven JacobsonCo-Founder & Independent Director | -26.00k | 1.75M | Derivative Exercise and Sale | 11.23 - 85.32 | 15.12k | - |
| 2025-11-21 | Ms. Emma ReeveIndependent Director | -10.00k | 283.40k | Derivative Exercise and Sale | 51.16 - 79.50 | 4.33k | - |
| 2025-11-20 | Ms. Stephanie Smith OkeyIndependent Director | -867.00 | 0.00 | Other Disposition | - | 5.67k | -13.27% |
| 2025-11-17 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -2.81k | 141.45k | Derivative Exercise and Sale | 25.69 - 77.18 | 103.90k | - |
| 2025-11-12 | Ms. Emma ReeveIndependent Director | -7.33k | 205.03k | Derivative Exercise and Sale | 46.54 - 74.50 | 4.33k | - |
| 2025-10-30 | Ms. Emma ReeveIndependent Director | -12.00k | 376.80k | Derivative Exercise and Sale | 38.10 - 69.50 | 4.33k | - |
| 2025-10-30 | Ms. Emma ReeveIndependent Director | -3.67k | 254.79k | Automatic Disposition | 69.50 | 4.33k | -45.83% |
| 2025-10-07 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -3.38k | 85.50k | Derivative Exercise and Sale | 38.10 - 64.97 | 103.90k | - |
| 2025-10-03 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -24.92k | 656.16k | Derivative Exercise and Sale | 39.42 - 67.15 | 103.90k | - |
| 2025-10-03 | Dr. Neil AlmsteadChief Technical Operations Officer | -55.00k | 1.94M | Derivative Exercise and Sale | 30.86 - 67.16 | 56.54k | - |
| 2025-10-03 | Dr. Allan Steven JacobsonCo-Founder & Independent Director | -12.00k | 409.68k | Derivative Exercise and Sale | 30.86 - 65.00 | 15.12k | - |
| 2025-10-03 | Ms. Emma ReeveIndependent Director | -25.56k | 772.69k | Derivative Exercise and Sale | 33.02 - 66.93 | 8.00k | - |
| 2025-09-11 | Ms. Emma ReeveIndependent Director | -10.84k | 359.75k | Derivative Exercise and Sale | 25.69 - 59.50 | 8.00k | - |
| 2025-09-11 | Ms. Emma ReeveIndependent Director | -4.87k | 289.65k | Automatic Disposition | 59.50 | 8.00k | -37.83% |
| 2025-09-11 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -47.25k | 1.09M | Derivative Exercise and Sale | 38.10 - 62.09 | 103.90k | - |
| 2025-09-09 | Mr. David P. SouthwellIndependent Director | -12.00k | 329.76k | Derivative Exercise and Sale | 30.86 - 58.34 | 14.52k | - |
| 2025-09-08 | Mr. Eric PauwelsChief Business Officer | -39.85k | 1.36M | Derivative Exercise and Sale | 11.23 - 56.94 | 20.06k | - |
| 2025-08-28 | Dr. Allan Steven JacobsonCo-Founder & Independent Director | -1.67k | 83.60k | 売り | 50.15 | 15.12k | -9.93% |
| 2025-08-15 | Mr. Mark Elliott BouldingExec. VP & Chief Legal Officer | -2.81k | 64.39k | Derivative Exercise and Sale | 25.69 - 48.58 | 103.90k | - |
| 2025-08-05 | Dr. Matthew B. KleinCEO & Director | -10.74k | 555.64k | 売り | 51.74 | 77.77k | -12.13% |
| 2025-07-15 | Mr. Pierre GravierCFO | -2.52k | 124.44k | 売り | 49.46 | 20.62k | -10.87% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
